Advertisement

The Indian Journal of Pediatrics

, Volume 86, Supplement 1, pp 15–19 | Cite as

Identifying Pathways Mediating Obstructive Sleep Apnea and Obesity in Indian Children

  • Giulia Lorenzoni
  • Danila Azzolina
  • Gulshan Sethi
  • Sanjay Manchanda
  • Dario Gregori
  • Achal Gulati
  • Ileana BaldiEmail author
Original Article

Abstract

Objective

Overweight and obesity in children is associated with several metabolic and cardiovascular impairments, including obstructive sleep apnea (OSA). However, the causal pathway from OSA to obesity is not fully known yet. The aim of this study was to explore the association between OSA and obesity-related metabolic outcomes in obese Indian children.

Methods

An observational, cross-sectional study was conducted. Obese children referred to the Otorhinolaryngology Department at the Maulana Azad Medical College (New Delhi, India) for suspicion of OSA were consecutively enrolled. OSA was diagnosed by polysomnographic parameters. Homeostasis model assessment (HOMA) was calculated to measure insulin sensitivity and HOMA > 4.39 was considered as a threshold for insulin resistance. The association between various polysomnographic measures and HOMA, adiponectin and various urinary catecholamines was assessed.

Results

Complete polysomnographic parameters were available for 45 children; of these 29 were found to suffer from OSA. OSA children had significantly higher glucose concentrations compared to non-OSA ones (p value = 0.012) but no differences were found in insulin resistance and urinary catecholamines levels. Older age was significantly associated to lower levels of catecholamines. No significant associations were found between polysomnographic parameters and both HOMA and adiponectin. Only age was found to be significantly associated with HOMA (p = 0.03) and adiponectin (p = 0.01).

Conclusions

A better understanding of the role played by OSA on obese children’s metabolic functions is crucial to implement specific prevention strategies to reduce the public health burden of non-communicable diseases.

Keywords

Obese children OSA Insulin resistance Catecholamines India 

Notes

Contributions

IB, AG, DG: Designed the study; IB, GL: Wrote the manuscript; DG, DA: Performed the statistical analysis; SM, GS: Critically revised the manuscript and contributed to the discussion. All authors contributed to results interpretation, read and approved the final manuscript. IB will act as guarantor for this paper.

Compliance with Ethical Standards

Conflict of Interest

None.

Source of Funding

This work is partially supported by an unrestricted grant within the Executive Programme of Scientific and Technological Cooperation between the Italian Republic and the Republic of India, agreed by Ministry of Foreign Affairs, Directorate General for the Country Promotion (Economy, Culture and Science) of the Republic of Italy and the Ministry of Science & Technology, Department of Science and Technology, of the Republic of India, and from Prochild ONLUS (Italy).

References

  1. 1.
    Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483–90.CrossRefGoogle Scholar
  2. 2.
    Ahrens W, Pigeot I, Pohlabeln H, et al. Prevalence of overweight and obesity in European children below the age of 10. Int J Obes. 2014;38:S99–107.CrossRefGoogle Scholar
  3. 3.
    Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2000;246:1–190.Google Scholar
  4. 4.
    Khadilkar V, Khadilkar A, Cole T, Chiplonkar S, Pandit D. Overweight and obesity prevalence and body mass index trends in Indian children. Int J Pediatr Obes. 2011;6:e216–e24.CrossRefGoogle Scholar
  5. 5.
    Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15:21–9.CrossRefGoogle Scholar
  6. 6.
    Weiss R, Kaufman FR. Metabolic complications of childhood obesity identifying and mitigating the risk. Diabetes Care. 2008;31:S310–6.CrossRefGoogle Scholar
  7. 7.
    Bridger T. Childhood obesity and cardiovascular disease. Paediatr Child Health. 2009;14:177–82.CrossRefGoogle Scholar
  8. 8.
    Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.Google Scholar
  9. 9.
    Carter R, Watenpaugh DE. Obesity and obstructive sleep apnea: or is it OSA and obesity? Pathophysiology. 2008;15:71–7.CrossRefGoogle Scholar
  10. 10.
    Mathew JL, Narang I. Sleeping too close together: obesity and obstructive sleep apnea in childhood and adolescence. Paediatr Respir Rev. 2014;15:211–8.Google Scholar
  11. 11.
    Narang I, Mathew JL. Childhood obesity and obstructive sleep apnea. J Nutr Metabol. 2012;2012.  https://doi.org/10.1155/2012/134202.
  12. 12.
    Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–904.CrossRefGoogle Scholar
  13. 13.
    Seetho IW, Wilding JP. Screening for obstructive sleep apnoea in obesity and diabetes–potential for future approaches. Eur J Clin Invest. 2013;43:640–55.CrossRefGoogle Scholar
  14. 14.
    Lihn A, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005;6:13–21.CrossRefGoogle Scholar
  15. 15.
    Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–9.CrossRefGoogle Scholar
  16. 16.
    Delporte M, Funahashi T, Takahashi M, Matsuzawa Y, Brichard S. Pre-and post-translational negative effect of β-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J. 2002;367:677–85.CrossRefGoogle Scholar
  17. 17.
    Kelly A, Dougherty S, Cucchiara A, Marcus CL, Brooks LJ. Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea. Sleep. 2010;33:1185–91.CrossRefGoogle Scholar
  18. 18.
    Snow AB, Khalyfa A, Serpero LD, et al. Catecholamine alterations in pediatr obstructive sleep apnea: effect of obesity. Pediatr Pulmonol. 2009;44:559–67.CrossRefGoogle Scholar
  19. 19.
    O’Driscoll DM, Horne RS, Davey MJ, et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med. 2011;12:483–8.CrossRefGoogle Scholar
  20. 20.
    Nisbet LC, Yiallourou SR, Nixon GM, et al. Nocturnal autonomic function in preschool children with sleep-disordered breathing. Sleep Med. 2013;14:1310–6.CrossRefGoogle Scholar
  21. 21.
    Kaditis AG, Alexopoulos EI, Damani E, et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol. 2009;44:38–45.CrossRefGoogle Scholar
  22. 22.
    WHO. Growth Reference Data for 5–19 years. Geneva: World Health Organization; 2007. Available at: http://www.who.int/growthref/en/. Accessed 29 Nov 2008.
  23. 23.
    Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM Manual for the Scoring Sleep and Associated Events: Rules, Terminology and Technical Specification, 1st ed. In: Westchester IL, editor. Westchester, Illinois: American Academy of Sleep Medicine; 2007.Google Scholar
  24. 24.
    Bhushan B, Khalyfa A, Spruyt K, et al. Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med. 2011;12:666–71.CrossRefGoogle Scholar
  25. 25.
    Alonso-Álvarez ML, Terán-Santos J, Martinez MG, et al. Metabolic biomarkers in community obese children: effect of obstructive sleep apnea and its treatment. Sleep Med. 2017;37:1–9.CrossRefGoogle Scholar
  26. 26.
    Kohler M, Lushington K, Couper R, et al. Obesity and risk of sleep related upper airway obstruction in Caucasian children. J Clin Sleep Med. 2008;4:129–36.Google Scholar
  27. 27.
    Rudnick EF, Walsh JS, Hampton MC, Mitchell RB. Prevalence and ethnicity of sleep-disordered breathing and obesity in children. Otolaryngol Head Neck Surg. 2007;137:878–82.CrossRefGoogle Scholar
  28. 28.
    Weinstock TG, Rosen CL, Marcus CL, et al. Predictors of obstructive sleep apnea severity in adenotonsillectomy candidates. Sleep. 2014;37:261–9.CrossRefGoogle Scholar
  29. 29.
    Pussard E, Neveux M, Guigueno N. Reference intervals for urinary catecholamines and metabolites from birth to adulthood. Clin Biochem. 2009;42:536–9.CrossRefGoogle Scholar
  30. 30.
    Pamidi S, Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol. 2012;3:126.CrossRefGoogle Scholar
  31. 31.
    Baldi I, Gulati A, Lorenzoni G, et al. Public health implications of obstructive sleep apnea burden. Indian J Pediatr. 2014;81:55–62.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  • Giulia Lorenzoni
    • 1
  • Danila Azzolina
    • 1
  • Gulshan Sethi
    • 2
  • Sanjay Manchanda
    • 3
  • Dario Gregori
    • 1
  • Achal Gulati
    • 4
  • Ileana Baldi
    • 1
    Email author
  1. 1.Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public HealthUniversity of PaduaPaduaItaly
  2. 2.Department of PediatricsMaulana Azad Medical CollegeNew DelhiIndia
  3. 3.Department of Sleep MedicineSir Ganga Ram HospitalNew DelhiIndia
  4. 4.Department of Otorhinolaryngology and Head and Neck SurgeryMaulana Azad Medical College and Associated Lok Nayak HospitalNew DelhiIndia

Personalised recommendations